Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Acetaminophen in pregnancy and autism: the claims and the evidence

    On 22 September 2025 the FDA began a label change saying acetaminophen use in pregnancy may be associated with a higher risk of autism and ADHD, while stating that a causal link has not been established.[1] ACOG and WHO said the evidence does not show that acetaminophen causes autism.[2][3] A large Swedish sibling-comparison study found no association. A 2025 umbrella review rated confidence in earlier reviews as low or critically low, and a 2026 one found that the link weakened toward no effect in higher-quality analyses.[4][5][6]

    Editor reviewedStrict sourcingUpdated Explainer14 claims · 100% primaryHealth and medicine, Pregnancy and reproductive health

    This page explains a public health claim and the research on it. It is general information, not medical advice, and it gives no guidance on doses. If you are pregnant, talk to a doctor, midwife or pharmacist before starting or stopping any medicine.

    What the FDA announced

    On 22 September 2025 the FDA began the process of changing the label of acetaminophen (Tylenol and similar products). The change reflects evidence suggesting that use in pregnancy may be associated with a higher risk of autism and ADHD in children. The agency said a causal relationship has not been established and that there are contrary studies.[1]

    It also sent a letter to physicians nationwide. FDA Commissioner Marty Makary said the choice still belongs with parents and that it remains reasonable for pregnant women to use acetaminophen in certain scenarios.[7] The FDA cited large cohort studies, including the Nurses’ Health Study II and the Boston Birth Cohort. It said some studies found the risk may be greatest with chronic use throughout pregnancy.[8]

    The same release noted that acetaminophen is the only over-the-counter drug approved to treat fever in pregnancy and that high fevers can harm the child.[9] It added that aspirin and ibuprofen have well-documented adverse effects on the fetus.[10]

    How medical bodies responded

    ACOG. On the same day, the American College of Obstetricians and Gynecologists said the HHS announcement was not backed by the full body of scientific evidence. It added that no reputable study had concluded that acetaminophen use in pregnancy causes neurodevelopmental disorders.[11] In a practice advisory that month, ACOG called acetaminophen the pain and fever medicine of choice in pregnancy and said the evidence does not support a causal link.[2]

    WHO. On 24 September 2025 the World Health Organization said there is no conclusive scientific evidence of a link between acetaminophen (paracetamol) in pregnancy and autism, and that no consistent association has been established.[3]

    What the studies show

    Why associations appear. ACOG’s advisory listed recurring weaknesses in the studies that find a link. Many rely on mothers’ own reports of what they took, and many fail to control for genetic and family factors.[12]

    Sibling comparisons. A 2024 JAMA study followed nearly 2.5 million children born in Sweden. Comparing all children, it found a marginally higher autism risk with exposure (hazard ratio 1.05). In its sibling-control analysis, which compares brothers and sisters to account for shared family factors, it found no association (hazard ratio 0.98).[4] ACOG said this study and a Norwegian sibling-controlled study were the only two that adequately addressed family factors, and that neither found a significant association.[12]

    A review that found a link. An August 2025 review in Environmental Health found that 27 of 46 included studies reported positive associations, 9 null associations and 4 negative associations, and said higher-quality studies were more likely to show positive associations. It concluded that the evidence is consistent with an association. One of its authors disclosed serving as an expert witness for plaintiffs in acetaminophen litigation.[13]

    Reviews of the reviews. A November 2025 umbrella review in The BMJ looked at nine systematic reviews. It rated confidence in their findings as low or critically low, and noted that seven of the nine urged caution because of bias and confounding.[5] A September 2026 umbrella review in Developmental Medicine & Child Neurology found small positive associations that weakened substantially, and in several models approached no effect, when it kept only higher-quality analyses and low-risk studies. It concluded that the evidence does not support a robust causal relationship.[6]

    What is known about autism’s causes

    WHO and the US National Institute of Mental Health say the main causes of autism are not known, and that genetic and environmental factors are probably both involved.[14] For more, see autism explained. For the administration’s wider children’s health agenda, see the MAHA report and strategy explained.

    The MAHA report and strategy explained

    What the 2025 Make America Healthy Again report and strategy say about childhood chronic disease, what they propose, and the criticism they drew.

    Questions readers ask

    What did the FDA announce about acetaminophen and autism?

    On 22 September 2025 it began a label change for acetaminophen (Tylenol and similar products). The new wording reflects evidence that use in pregnancy may be associated with a higher risk of autism and ADHD. The FDA also said a causal relationship has not been established and that there are contrary studies. It sent a letter to physicians nationwide.[1][7]

    Does acetaminophen in pregnancy cause autism?

    That has not been shown. The FDA said a causal relationship has not been established. WHO said there is no conclusive evidence of a link, and ACOG said the weight of evidence does not support a causal link.[1][3][2]

    Why do some studies find a link?

    Several large cohort studies have found an association. ACOG says many of them rely on mothers' own reports of use and do not control for genetic and family factors that affect both medicine use and autism risk.[8][12]

    What did the large Swedish study find?

    A 2024 JAMA study of nearly 2.5 million children found a marginally higher autism risk in standard models (hazard ratio 1.05). When siblings were compared, it found no association (hazard ratio 0.98).[4]

    What are the alternatives for fever or pain in pregnancy?

    The FDA said acetaminophen is the only over-the-counter drug approved to treat fever in pregnancy, that high fevers can pose a risk to the child, and that aspirin and ibuprofen have well-documented adverse effects on the fetus. Ask a doctor, midwife or pharmacist about your own situation.[9][10]

    Sources

    · 14 claims from 8 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      On 22 September 2025 the FDA began a label change for acetaminophen to reflect evidence that use in pregnancy may be associated with higher risk of autism and ADHD, while stating that a causal relationship has not been established and contrary studies exist. confirmedas of 2025-09-22

    2. [2]

      In a September 2025 practice advisory, ACOG reaffirmed acetaminophen as the pain and fever medicine of choice in pregnancy and said the current weight of evidence does not support a causal link to neurodevelopmental disorders. confirmedas of 2025-09-30

    3. [3]

      On 24 September 2025 WHO said there is no conclusive scientific evidence of a link between acetaminophen (paracetamol) use in pregnancy and autism, and that no consistent association has been established. confirmedas of 2025-09-24

    4. [4]

      A 2024 JAMA study of nearly 2.5 million children born in Sweden found a marginally higher autism risk with acetaminophen use in pregnancy in standard models (hazard ratio 1.05), but no association in sibling-comparison analyses (hazard ratio 0.98). confirmedas of 2024-04-09

    5. [5]

      A November 2025 BMJ umbrella review of nine systematic reviews rated confidence in their findings as low to critically low and said most of the reviews urged caution because of possible bias and confounding. confirmedas of 2025-11-09

    6. [6]

      A September 2026 umbrella review in Developmental Medicine & Child Neurology found small positive associations that were substantially attenuated, and in several models approached no effect, in higher-quality analyses, and concluded the evidence does not support a robust causal relationship. confirmedas of 2026-09-23

    7. [7]

      Alongside the 22 September 2025 label-change process, the FDA issued a letter alerting physicians nationwide, and FDA Commissioner Marty Makary said the choice still belonged with parents and that it remained reasonable for pregnant women to use acetaminophen in certain scenarios. confirmedas of 2025-09-22

    8. [8]

      The FDA said multiple large cohort studies, including the Nurses' Health Study II and the Boston Birth Cohort, found an association, and that some studies described the risk as most pronounced with chronic use throughout pregnancy. confirmedas of 2025-09-22

    9. [9]

      The FDA noted that acetaminophen is the only over-the-counter drug approved to treat fever in pregnancy and that high fevers can pose a risk to the child. confirmedas of 2025-09-22

    10. [10]

      The FDA noted that aspirin and ibuprofen have well-documented adverse effects on the fetus. confirmedas of 2025-09-22

    11. [11]

      On 22 September 2025 the American College of Obstetricians and Gynecologists (ACOG) said the HHS announcement was not backed by the full body of scientific evidence and that no reputable study had concluded acetaminophen use in pregnancy causes neurodevelopmental disorders. confirmedas of 2025-09-22

    12. [12]

      ACOG's advisory said many studies linking prenatal acetaminophen to neurodevelopmental outcomes relied on maternal self-report and failed to control for genetic and familial confounders, and that only two sibling-controlled studies adequately addressed those factors, both finding no significant association. confirmedas of 2025-09-30

    13. [13]

      An August 2025 review in Environmental Health, using the Navigation Guide method, found 27 of 46 included studies reported positive associations (9 null, 4 negative), said higher-quality studies were more likely to show positive associations, and concluded the evidence was consistent with an association; one author disclosed serving as an expert witness for plaintiffs in acetaminophen litigation. confirmedas of 2025-08-14

    14. [14]

      The primary causes of autism are not known; WHO and NIMH say genetic and environmental factors are probably both involved. confirmedas of 2026-11-07

    Revision history (1)
    1. Page created.

    Created Nov 14, 2026. Last reviewed by an editor on Nov 15, 2026. Next scheduled review: Nov 14, 2027.

    Cite this page

    "Acetaminophen in pregnancy and autism: the claims and the evidence." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/acetaminophen-autism-claims-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.